I absolutely did not, but you are missing my point. The market seemed to always price in the inevitability of such an event, and they appear to be doing the same thing in regards to mCopax.
It seems the stance the market took with mEnox and is now taking with mCopax is that there are just too many variables, any one of which could torpedo the stock price, and as a result the present value of the stock is valued extremely conservatively.
Do you disagree with this? How else can you explain the mEnox scenario as it played out and even recent events with mCopax? Does it make sense to you that the gains related to the court case victory would have disappeared this quickly were this not true?
MNTA is less than 1 year away from possibly selling their generic of a multi-billion dollar drug (perhaps alone) and the market seems to discount its current valuation heavily. I can only assume this is due to heavy skepticism that it will play out as many here assume it will.
MNTA's stock price never made sense to me with mEnox but after witnessing how it played out it makes all the sense in the world to me today.
Market Data 
Markets 
AI
